| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Award | $47,902,710 | +55,132 | +11% | $868.88 | 539,613 | 10 Feb 2025 | Direct | |
| holding | LLY | Common Stock | 59,457 | 10 Feb 2025 | By David A. Ricks 2022 GRAT | ||||||
| holding | LLY | Common Stock | 68,656 | 10 Feb 2025 | By David A. Ricks SLAT | F1 | |||||
| holding | LLY | Common Stock | 300 | 10 Feb 2025 | By Trust | F1 | |||||
| holding | LLY | Common Stock | 7,265 | 10 Feb 2025 | 401(k) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Award | $0 | +31,932 | $0.000000 | 31,932 | 10 Feb 2025 | Common Stock | 31,932 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |